Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Kidney Transplant Recipients”

Showing 20 of 0 results

Post-approval studies (Phase 4)Ended earlyNCT00956293
What this trial is testing

Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 207
Post-approval studies (Phase 4)Study completedNCT03713645
What this trial is testing

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Temple University 36
Not applicableUnknownNCT01982903
What this trial is testing

Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants

Who this might be right for
Kidney Failure
Universitaire Ziekenhuizen KU Leuven 180
Large-scale testing (Phase 3)Study completedNCT01023815
What this trial is testing

Once-a-day Regimen With Everolimus, Low Dose Cyclosporine and Steroids in Comparison With Steroid Withdrawal or Twice a Day Regimen With Everolimus, Low Dose Cyclosporine and Steroids.

Who this might be right for
de Novo Kidney Transplant RecipientsRenal Transplantation
Novartis 330
Post-approval studies (Phase 4)Study completedNCT01649427
What this trial is testing

Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

Who this might be right for
Pharmacokinetics Study in de Novo Kidney Transplantation
Novartis Pharmaceuticals 73
Large-scale testing (Phase 3)Study completedNCT00413920
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium and Cyclosporine in Combination With and Without Steroids, in Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 222
Not applicableStudy completedNCT00079222
What this trial is testing

Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Cancer
Jonsson Comprehensive Cancer Center
Post-approval studies (Phase 4)Study completedNCT00240955
What this trial is testing

Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients

Who this might be right for
Renal Transplantation
Novartis 79
Post-approval studies (Phase 4)Study completedNCT01802268
What this trial is testing

Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Helio Tedesco Silva Junior 320
Large-scale testing (Phase 3)Ended earlyNCT00311311
What this trial is testing

Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

Who this might be right for
AtherosclerosisKidney Failure
Pfizer 72
Testing effectiveness (Phase 2)Study completedNCT00257387
What this trial is testing

Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

Who this might be right for
Kidney Transplant
Wyeth is now a wholly owned subsidiary of Pfizer 120
Early research (Phase 1)Ended earlyNCT01163799
What this trial is testing

A Pilot Study to Assess the Safety and Efficacy of Alefacept in de Novo Kidney Transplant Recipients

Who this might be right for
Transplant; Failure, Kidney
Northwestern University 9
Post-approval studies (Phase 4)Study completedNCT00518375
What this trial is testing

Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

Who this might be right for
Kidney Transplantation
Wyeth is now a wholly owned subsidiary of Pfizer 250
Large-scale testing (Phase 3)Study completedNCT00239876
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 140
Testing effectiveness (Phase 2)Study completedNCT00403416
What this trial is testing

Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 215
Large-scale testing (Phase 3)Ended earlyNCT00284921
What this trial is testing

MYPROMS-ES02: Safety and Efficacy of Basiliximab, Cyclosporine Microemulsion and Enteric-coated Mycophenolate Sodium (EC-MPS) Versus EC-MPS and Steroid Therapy in Kidney Transplant Recipients Who Are Hepatitis C Positive

Who this might be right for
De Novo Kidney Transplant
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT02137239
What this trial is testing

Regimen Optimization Study

Who this might be right for
Kidney Transplantation
Bristol-Myers Squibb 58
Large-scale testing (Phase 3)Study completedNCT00239811
What this trial is testing

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Large-scale testing (Phase 3)Study completedNCT00238992
What this trial is testing

Study of Enteric-coated Mycophenolate Sodium (EC-MPS) With Steroid Withdrawal vs EC-MPS With Standard Steroid Regimen in de Novo Renal Transplant Recipients.

Who this might be right for
Kidney de Novo Transplant
Novartis Pharmaceuticals 144
Post-approval studies (Phase 4)Study completedNCT03968588
What this trial is testing

Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

Who this might be right for
Disorder Related to Renal Transplantation
Ajou University School of Medicine 108
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation